Search Results - "Mulder, N H"

Treatment with intramuscular vascular endothelial growth factor gene compared with placebo for patients with diabetes mellitus and critical limb ischemia: a double-blind randomized trial by Kusumanto, Y H, van Weel, V, Mulder, N H, Smit, A J, van den Dungen, J J A M, Hooymans, J M M, Sluiter, W J, Tio, R A, Quax, P H A, Gans, R O B, Dullaart, R P F, Hospers, G A P

“…Despite advances in revascularization techniques, limb salvage and relief of pain cannot be achieved in many diabetic patients with diffuse peripheral vascular…”
Get more information

Cardiovascular Morbidity in Long-Term Survivors of Metastatic Testicular Cancer by MEINARDI, M. T, GIETEMA, J. A, KOOPS, H. S, SLEIJFER, D. T, VAN DER GRAAF, W. T. A, VAN VELDHUISEN, D. J, RUNNE, M. A, SLUITER, W. J, DE VRIES, E. G. E, WILLEMSE, P. B. H, MULDER, N. H, VAN DEN BERG, M. P

“…To determine whether long-term survivors of metastatic testicular cancer have an increased risk of cardiovascular morbidity more than 10 years after…”
Get full text

Survival of non-Western first generations immigrants with stomach cancer in North East Netherlands by Siemerink, E J M, van der Aa, M A, Siesling, S, Hospers, G A P, Mulder, N H

“…Background: Isolated groups, such as first generation non-Western immigrants, are at risk for suboptimal utilisation of the health care system resulting in a…”
Get full text

A favourable pathological stage after neoadjuvant radiochemotherapy in patients with initially irresectable rectal cancer correlates with a favourable prognosis by Reerink, O., Verschueren, R.C.J., Szabo, B.G., Hospers, G.A.P., Mulder, N.H.

“…Initial treatments of locally advanced rectal cancers focus on local control, as local relapse of a rectal cancer is correlated with a high morbidity and…”
Get full text

[18F]FHPG Positron Emission Tomography for Detection of Herpes Simplex Virus (HSV) in Experimental HSV Encephalitis by BUURSMA, A. R, DE VRIES, E. F. J, GARSSEN, J, KEGLER, D, VAN WAARDE, A, SCHIRM, J, HOSPERS, G. A. P, MULDER, N. H, VAALBURG, W, KLEIN, H. C

“…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

Continuously infused carboplatin used as radiosensitizer in locally unresectable non-small-cell lung cancer: a multicenter phase III study by Groen, H. J. M., van der Leest, A. H. W., Fokkema, E., Timmer, P. R., Nossent, G. D., Smit, W. J. G. M., Nabers, J., Hoekstra, H. J., Hermans, J., Otter, R., van Putten, J. W. G., de Vries, E. G. E., Mulder, N. H.

“…Purpose: To determine the radiosensitizing effect of prolonged exposure of carboplatin in patients with locally unresectable non-small-cell lung cancer…”
Get full text

Randomised Phase III study of biweekly 24-h infusion of high-dose 5FU with folinic acid and oxaliplatin versus monthly plus 5-FU/folinic acid in first-line treatment of advanced colorectal cancer by Hospers, G. A. P., Schaapveld, M., Nortier, J. W. R., Wils, J., van Bochove, A., de Jong, R. S., Creemers, G. J., Erjavec, Z., de Gooyer, D. J., Slee, P. H. Th. J., Gerrits, C. J. H., Smit, J. M., Mulder, N. H.

“…Background: A phase III study was started to compare oxaliplatin/5FU/LV in the first-line with bolus FU/LV in metastatic colorectal cancer. Patients and…”
Get full text

Telomere length in breast cancer patients before and after chemotherapy with or without stem cell transplantation by SCHRÖDER, C. P, WISMAN, G. B. A, DE JONG, S, VAN DER GRAAF, W. T. A, RUITERS, M. H. J, MULDER, N. H, DE LEIJ, L. F. M. H, VAN DER ZEE, A. G. J, DE VRIES, E. G. E

“…High-dose chemotherapy and peripheral blood stem cell transplantation (PBSCT) may accelerate telomere length loss in haematopoietic stem cells. As data…”
Get full text

Overexpression of the Gene Encoding the Multidrug Resistance-Associated Protein Results in Increased ATP-Dependent Glutathione S-Conjugate Transport by Muller, Michael, Meijer, Coby, Guido J. R. Zaman, Borst, Piet, Scheper, Rik J., Mulder, Nanno H., Elisabeth G. E. de Vries, Peter L. M. Jansen

“…The multidrug resistance-associated protein (MRP) is a 180- to 195-kDa glycoprotein associated with multidrug resistance of human tumor cells. MRP is mainly…”
Get full text

Modulation of cis-diamminedichloroplatinum(II) resistance: a review by TIMMER-BOSSCHA, H, MULDER, N. H, DE VRIES, E. G. E

“…In this review an inventory is made of agents used to circumvent cis-diamminedichloroplatinum(II) (CDDP) resistance in vitro and in vivo. Agents that affect…”
Get full text

Early detection of anthracycline induced cardiotoxicity in asymptomatic patients with normal left ventricular systolic function: autonomic versus echocardiographic variables by Tjeerdsma, G, Meinardi, M T, van der Graaf, W T A, van den Berg, M P, Mulder, N H, Crijns, H J G M, de Vries, E G E, van Veldhuisen, D J

“…OBJECTIVE To investigate left ventricular dysfunction in patients who had been treated with anthracycline based chemotherapy. METHODS Autonomic function was…”
Get full text

Value and cost of follow-up after adjuvant treatment of patients with Dukes' C colonic cancer by Bleeker, W. A., Mulder, N. H., Hermans, J., Otter, R., Plukker, J. T. M.

“…Background: The clinical value and costs of different diagnostic tools used to identify potentially curable recurrent disease in patients treated adjuvantly…”
Get full text

Skin capillary permeability in the diabetic foot with critical limb ischaemia: the effects of a phVEGF165 gene product by De Leeuw, K., Kusumanto, Y., Smit, A. J., Oomen, P., Van Der Hoeven, J. H., Mulder, N. H., Hospers, G. A. P.

“…Aims   To measure capillary permeability, assessed by skin capillary sodium fluorescein (NaF) leakage, in patients with diabetes mellitus with critical limb…”
Get full text

Effects of Recombinant Human Interleukin-6 in Cancer Patients: A Phase I-II Study by van Gameren, Mieke M., Willemse, Pax H.B., Mulder, Nanno H., Limburg, Pieter C., Groen, Harry J.M., Vellenga, Edo, de Vries, Elisabeth G.E.

“…To define the toxicity profile of recombinant human interleukin-6 (rhlL-6) and to study its effect on hematopoiesis, biochemical parameters and other…”
Get full text

Factors influencing catheter-related infections in the Dutch multicenter study on high-dose chemotherapy followed by peripheral SCT in high-risk breast cancer patients by Nieboer, P, de Vries, E G E, Mulder, N H, Rodenhuis, S, Bontenbal, M, van der Wall, E, van Hoesel, Q G, Smit, W M, Hupperets, P, Voest, E E, Nooij, M A, Boezen, H M, van der Graaf, W T A

“…Neutropenia following high-dose chemotherapy leads to a high incidence of infectious complications, of which central venous catheter-related infections…”
Get full text

Phase II study of subcutaneous interleukin-2 in unselected patients with advanced renal cell cancer on an outpatient basis by Sleijfer, D T, Janssen, R A, Buter, J, de Vries, E G, Willemse, P H, Mulder, N H

“…A single-institution phase II study was undertaken to evaluate the efficacy and toxicity of interleukin-2 (IL-2) administered by subcutaneous injection…”
Get more information

Factors influencing haematological recovery following high-dose chemotherapy and peripheral stem-cell transplantation for haematological malignancies: 1-year analysis by Nieboer, P., de Vries, E.G.E., Vellenga, E., van der Graaf, W.T.A., Mulder, N.H., Sluiter, W.J., de Wolf, J.Th.M.

“…Peripheral blood counts and factors influencing haematological recovery in 98 patients with a relapse-free survival of ⩾1 year treated with high-dose…”
Get full text

Randomized placebo-controlled trial of granulocyte-macrophage colony-stimulating factor in patients with chemotherapy-related febrile neutropenia by Vellenga, E, Uyl-de Groot, C A, de Wit, R, Keizer, H J, Löwenberg, B, ten Haaft, M A, de Witte, T J, Verhagen, C A, Stoter, G J, Rutten, F F, Mulder, N H, Smid, W M, de Vries, E G

“…To determine whether granulocyte-macrophage colony-stimulating factor (GM-CSF) used in addition to standard inpatient antibiotic therapy shortens the period of…”
Get more information

Phase I and pharmacokinetic study of the topoisomerase II catalytic inhibitor fostriecin by DE JONG, R. S, MULDER, N. H, UGES, D. R. A, SLEIJFER, D. T, HÖPPENER, F. J. P, GROEN, H. J. M, WILLEMSE, P. H. B, VAN DER GRAAF, W. T. A, DE VRIES, E. G. E

“…We conducted a phase I and pharmacokinetic study of the topoisomerase II catalytic inhibitor fostriecin. Fostriecin was administered intravenously over 60 min…”
Get full text

Recombinant Human Interleukin-6 Induces a Rapid and Reversible Anemia in Cancer Patients by Nieken, Judith, Mulder, Nanno H., Buter, Jan, Vellenga, Edo, Limburg, Pieter C., Piers, Do A., de Vries, Elisabeth G.E.

“…Initial studies have shown that recombinant human interleukin-6 (rhlL-6) induces anemia. Until now, the pathophysiologic mechanism of this induced anemia has…”
Get full text